Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima Porten

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
European Urology Focus|July 30, 2017
Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical CystectomyJanet Baack Kukreja, Sima Porten, Vishnukamal Golla, et al.
Urology|April 22, 2024
Predicting Peak Productivity in Urologic Medicare Practice via Work-Relative Value UnitsLogan G Briggs, Muhieddine Labban, Jamie Ye, et al.
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 6, 2022
Use of a Convex Pouching System in the Postoperative Period: A National ConsensusJanice C Colwell, Janet Stoia Davis, Krisztina Emodi, et al.
Oncotarget|August 6, 2016
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisBeat Roth, Isuru Jayaratna, Debasish Sundi, et al.
European Urology|September 7, 2015
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial CancerDavid J McConkey, Woonyoung Choi, Yu Shen, et al.
Urologic Oncology|February 2, 2024
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trialsYair Lotan, Piyush Agarwal, Peter Black, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Initial Experience with <sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial CancerVadim S Koshkin, Vipul Kumar, Brad Kline, et al.
European Urology Focus|July 8, 2023
Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non-muscle-invasive Bladder Cancer (BRIDGE)Max Kates, Xiangying Chu, Noah Hahn, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Commentary on Novitas LCDYair Lotan, Daniel A Barocas, Sam S Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2026
Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder CancerYair Lotan, Michael Luu, Menghan Liu, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
European Urology Focus|July 30, 2017
Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical CystectomyJanet Baack Kukreja, Sima Porten, Vishnukamal Golla, et al.
Urology|April 22, 2024
Predicting Peak Productivity in Urologic Medicare Practice via Work-Relative Value UnitsLogan G Briggs, Muhieddine Labban, Jamie Ye, et al.
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 6, 2022
Use of a Convex Pouching System in the Postoperative Period: A National ConsensusJanice C Colwell, Janet Stoia Davis, Krisztina Emodi, et al.
Oncotarget|August 6, 2016
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisBeat Roth, Isuru Jayaratna, Debasish Sundi, et al.
European Urology|September 7, 2015
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial CancerDavid J McConkey, Woonyoung Choi, Yu Shen, et al.
Urologic Oncology|February 2, 2024
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trialsYair Lotan, Piyush Agarwal, Peter Black, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Initial Experience with <sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial CancerVadim S Koshkin, Vipul Kumar, Brad Kline, et al.
European Urology Focus|July 8, 2023
Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non-muscle-invasive Bladder Cancer (BRIDGE)Max Kates, Xiangying Chu, Noah Hahn, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Commentary on Novitas LCDYair Lotan, Daniel A Barocas, Sam S Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2026
Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder CancerYair Lotan, Michael Luu, Menghan Liu, et al.
Pageof 5